Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity.

Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity. - Effect BoNT-A on spasticity.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48057

Enrollment

Registered

2020-02-18

Start date

2020-02-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular accident / Spinal cord injury myelophathy Stroke

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - a minimum of 6 months post-lesion/post-stroke to ensure that the participant has a stable neurological condition, without clinical alterations - age 18 years or older at the time of the study - spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score * 1 - have an ankle joint range of motion of at least 20° in the sagittal plane - ability to make a transfer on to the Achilles (medical device) - current treatment of any/all of the m. tricpes surae with BoNT-A for spasticity reduction

Exclusion criteria

Exclusion criteria: - have a MAS/Tardieu score of 4 - receive BoNT-A combined with other therapies aimed at reducing spasticity

Design outcomes

Primary

Measure	Time frame
The primary study parameter is the reflexive joint resistance measured across 3 sessions.	—

Secondary

Measure	Time frame
The secundary study parameters are the reflexive and intrinsic joint resistance measured across 3 sessions.	—

Countries

Netherlands

Outcome results